E-mail us: service@prospectnews.com Or call: 212 374 2800
Bank Loans - CLOs - Convertibles - Distressed Debt - Emerging Markets
Green Finance - High Yield - Investment Grade - Liability Management
Preferreds - Private Placements - Structured Products
 
Published on 10/26/2006 in the Prospect News Biotech Daily.

IntraLase reiterated at outperform by JMP

IntraLase Corp. was reiterated by JMP Securities analyst Anthony Ostrea at market outperform with a $25 price target. The company's third-quarter 2006 total revenue came in at $32.3 million, up 41% from last year and exceeding JMP's $30.7 million estimate. GAAP earnings per share came in at $0.09, lower than Ostrea's $0.17 estimate and the Street's $0.16. According to Ostrea, investors should focus on the solid top-line growth (lasers, procedures). JMP increased its 2008 revenue estimate to $156.1 million, from $154.0 million and maintained its 2008 GAAP earnings per share estimate of $0.90. Shares of the Irvine, Calif.-based vision laser products company were up 8 cents, or 0.42%, at $19.14. (Nasdaq: ILSE)


© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.